[S02DA03, antipyrine, Antipyrine may decrease the antihypertensive activities of Amlodipine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Amlodipine.]
[L04AA27, fingolimod, Amlodipine may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Amlodipine.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Amlodipine can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sulfisoxazole.]
[M01AB02, sulindac, Sulindac may decrease the antihypertensive activities of Amlodipine.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glymidine.]
[M01AX04, apazone, Azapropazone may decrease the antihypertensive activities of Amlodipine.]
[L02BA01, tamoxifen, The metabolism of Amlodipine can be increased when combined with Tamoxifen.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Amlodipine.]
[G03BA03, testosterone, The metabolism of Amlodipine can be increased when combined with Testosterone.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Amlodipine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Thalidomide.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Amlodipine.]
[N05AB08, thioproperazine, The risk or severity of hypotension can be increased when Thioproperazine is combined with Amlodipine.]
[N05AC02, thioridazine, The risk or severity of hypotension can be increased when Thioridazine is combined with Amlodipine.]
[C01BB04, aprindine, Amlodipine may increase the arrhythmogenic activities of Aprindine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Amlodipine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Amlodipine is combined with Timolol.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Tolazamide.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Tolazoline is combined with Amlodipine.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Tolbutamide.]
[M02AA21, tolmetin, Tolmetin may decrease the antihypertensive activities of Amlodipine.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Amlodipine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Amlodipine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Amlodipine is combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Amlodipine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Amlodipine is combined with Triamterene.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Trichlormethiazide.]
[N05AB06, trifluoperazine, The risk or severity of hypotension can be increased when Trifluoperazine is combined with Amlodipine.]
[R03BA07, mometasone, The metabolism of Amlodipine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Amlodipine may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, Amlodipine may increase the arrhythmogenic activities of Metipranolol.]
[N03AC02, trimethadione, Trimethadione may increase the arrhythmogenic activities of Amlodipine.]
[C02BA01, trimethaphan, Amlodipine may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Trimethoprim.]
[N06AA06, trimipramine, The risk or severity of hypotension can be increased when Trimipramine is combined with Amlodipine.]
[J01FA08, troleandomycin, The metabolism of Amlodipine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Amlodipine.]
[C09CA09, azilsartan medoxomil, Amlodipine may increase the hypotensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, Amlodipine may increase the neuromuscular blocking activities of Tubocurarine.]
[A10BH05, linagliptin, The metabolism of Amlodipine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Amlodipine can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Amlodipine can be decreased when combined with Telaprevir.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Amlodipine.]
[C08DA01, verapamil, Amlodipine may increase the arrhythmogenic activities of Verapamil.]
[N06AX09, viloxazine, The metabolism of Amlodipine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Amlodipine can be increased when combined with Vinblastine.]
[C04AX07, vincamine, Amlodipine may increase the hypotensive activities of Vincamine.]
[A11HA03, vitamin E, The metabolism of Amlodipine can be increased when combined with Vitamin E.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Amlodipine.]
[C03BA10, xipamide, Amlodipine may increase the hypotensive activities of Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of hypotension can be increased when Zuclopenthixol is combined with Amlodipine.]
[J05AE02, indinavir, The metabolism of Amlodipine can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Amlodipine can be increased when combined with Vemurafenib.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Amlodipine.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Ziprasidone.]
[G03AC10, drospirenone, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Drospirenone.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Amlodipine.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Amlodipine.]
[C07AB03, atenolol, Atenolol may increase the arrhythmogenic activities of Amlodipine.]
[L01FA01, rituximab, Amlodipine may increase the hypotensive activities of Rituximab.]
[J02AC03, voriconazole, The metabolism of Amlodipine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, Amlodipine may increase the neuromuscular blocking activities of Atracurium.]
[S01FA01, atropine, Amlodipine may increase the arrhythmogenic activities of Atropine.]
[H02AB11, prednylidene, The metabolism of Amlodipine can be increased when combined with Prednylidene.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Amlodipine.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Amlodipine.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Amlodipine.]
[V03AX03, cobicistat, The metabolism of Amlodipine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Amlodipine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Amlodipine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Amlodipine.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Amlodipine.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Amlodipine.]
[L01EX05, regorafenib, Amlodipine may increase the bradycardic activities of Regorafenib.]
[N05CA04, barbital, The metabolism of Amlodipine can be increased when combined with Barbital.]
[C01AA01, acetyldigitoxin, Amlodipine may increase the arrhythmogenic activities of Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Amlodipine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Amlodipine.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Amlodipine.]
[C08CA13, lercanidipine, Amlodipine may increase the arrhythmogenic activities of Lercanidipine.]
[N06DA02, donepezil, Amlodipine may increase the bradycardic activities of Donepezil.]
[N03AX22, perampanel, The metabolism of Amlodipine can be increased when combined with Perampanel.]
[L04AA29, tofacitinib, Amlodipine may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Amlodipine.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Amlodipine.]
[H01CB05, pasireotide, Amlodipine may increase the bradycardic activities of Pasireotide.]
[G04BE03, sildenafil, Sildenafil may increase the antihypertensive activities of Amlodipine.]
[C04AX11, bencyclane, Amlodipine may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Alogliptin.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Bendroflumethiazide.]
[N02BA10, benorilate, Benorilate may decrease the antihypertensive activities of Amlodipine.]
[A10BK02, canagliflozin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Canagliflozin.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Amlodipine.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Amlodipine.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Pramlintide.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Amlodipine.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Amlodipine.]
[L01EC02, dabrafenib, The metabolism of Amlodipine can be increased when combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the antihypertensive activities of Amlodipine.]
[C08EA02, bepridil, Amlodipine may increase the arrhythmogenic activities of Bepridil.]
[C02KX05, riociguat, Amlodipine may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Lixisenatide.]
[C02KX04, macitentan, Amlodipine may increase the hypotensive activities of Macitentan.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Amlodipine.]
[N03AF04, eslicarbazepine, The metabolism of Amlodipine can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Amlodipine can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Dapagliflozin.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Amlodipine.]
[C07AB04, acebutolol, Amlodipine may increase the arrhythmogenic activities of Acebutolol.]
[A16AA07, metreleptin, The metabolism of Amlodipine can be increased when combined with Metreleptin.]
[L02BG02, formestane, The metabolism of Amlodipine can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Amlodipine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Betaxolol may increase the arrhythmogenic activities of Amlodipine.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Amlodipine.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Albiglutide.]
[L01ED02, ceritinib, Amlodipine may increase the bradycardic activities of Ceritinib.]
[A03BA03, hyoscyamine, Amlodipine may increase the arrhythmogenic activities of Hyoscyamine.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Empagliflozin.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Amlodipine.]
[S01EE02, unoprostone, Amlodipine may increase the hypotensive activities of Unoprostone.]
[N05AA04, acepromazine, The risk or severity of hypotension can be increased when Acepromazine is combined with Amlodipine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Amlodipine.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Dulaglutide.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amlodipine.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Amlodipine.]
[N02BE01, acetaminophen, The metabolism of Amlodipine can be increased when combined with Acetaminophen.]
[C01EB17, ivabradine, Amlodipine may increase the bradycardic activities of Ivabradine.]
[N05AX16, brexpiprazole, The risk or severity of hypotension can be increased when Brexpiprazole is combined with Amlodipine.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Amlodipine.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Amlodipine.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Amlodipine.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Acarbose.]
[M02AA25, aceclofenac, Aceclofenac may decrease the antihypertensive activities of Amlodipine.]
[M01AB11, acemetacin, Acemetacin may decrease the antihypertensive activities of Amlodipine.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin degludec.]
[J02AC05, isavuconazole, The metabolism of Amlodipine can be decreased when combined with Isavuconazole.]
[B01AC27, selexipag, Amlodipine may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Acetohexamide.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Amlodipine.]
[N05CA05, aprobarbital, The metabolism of Amlodipine can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the antihypertensive activities of Amlodipine.]
[L01XX52, venetoclax, The metabolism of Amlodipine can be decreased when combined with Venetoclax.]
[N04BC01, bromocriptine, The risk or severity of hypotension can be increased when Bromocriptine is combined with Amlodipine.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Amlodipine.]
[S01AA13, fusidic acid, The metabolism of Amlodipine can be decreased when combined with Fusidic acid.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Amlodipine.]
[C07AA19, bupranolol, Amlodipine may increase the arrhythmogenic activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Amlodipine.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, Amlodipine may increase the bradycardic activities of Rivastigmine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Amlodipine.]
[L01EF02, ribociclib, The metabolism of Amlodipine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the antihypertensive activities of Amlodipine.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Amlodipine.]
[N02BF02, pregabalin, Pregabalin may increase the bradycardic activities of Amlodipine.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Benfluorex.]
[D05AX03, calcitriol, The metabolism of Amlodipine can be increased when combined with Calcitriol.]
[G04BA03, calcium chloride, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium chloride.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Amlodipine.]
[J05AE09, tipranavir, The metabolism of Amlodipine can be decreased when combined with Tipranavir.]
[D11AX03, calcium gluconate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium gluconate.]
[L01EX10, midostaurin, The metabolism of Amlodipine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Amlodipine.]
[D01AC10, bifonazole, The therapeutic efficacy of Bifonazole can be increased when used in combination with Amlodipine.]
[P03AC02, bioallethrin, Amlodipine may increase the arrhythmogenic activities of Bioallethrin.]
[L01XX59, enasidenib, The metabolism of Amlodipine can be increased when combined with Enasidenib.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Amlodipine.]
[J05AG03, efavirenz, The serum concentration of Amlodipine can be decreased when it is combined with Efavirenz.]
[C07AA17, bopindolol, The risk or severity of bradycardia can be increased when Amlodipine is combined with Bopindolol.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Nesiritide.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Canrenone.]
[R03BA02, budesonide, The metabolism of Amlodipine can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Amlodipine.]
[M01AB07, bumadizone, Bumadizone may decrease the antihypertensive activities of Amlodipine.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Amlodipine.]
[C01AA02, acetyldigoxins, Amlodipine may increase the arrhythmogenic activities of Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Semaglutide.]
[A10BK04, ertugliflozin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Ertugliflozin.]
[C09AA01, captopril, Amlodipine may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, The metabolism of Amlodipine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Amlodipine can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Amlodipine.]
[C07AG02, carvedilol, Amlodipine may increase the arrhythmogenic activities of Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may increase the antihypertensive activities of Amlodipine.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Amlodipine.]
[C07AB08, celiprolol, Amlodipine may increase the arrhythmogenic activities of Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Amlodipine can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Amlodipine can be decreased when combined with Stiripentol.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Carbutamide.]
[M01AC05, lornoxicam, Lornoxicam may decrease the antihypertensive activities of Amlodipine.]
[L01ED05, lorlatinib, The metabolism of Amlodipine can be increased when combined with Lorlatinib.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amlodipine.]
[C01BG07, cifenline, Amlodipine may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, Amlodipine may increase the hypotensive activities of Cilazapril.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Amlodipine.]
[S01ED05, carteolol, Amlodipine may increase the arrhythmogenic activities of Carteolol.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Amlodipine.]
[J01FA09, clarithromycin, The risk or severity of adverse effects can be increased when Clarithromycin is combined with Amlodipine.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Amlodipine.]
[N05BA09, clobazam, The metabolism of Amlodipine can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Amlodipine can be increased when combined with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Amlodipine.]
[V03AE07, calcium acetate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, Amlodipine may increase the hypotensive activities of Candesartan.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Amlodipine.]
[H02AB17, cortivazol, The metabolism of Amlodipine can be increased when combined with Cortivazol.]
[C03BX03, cicletanine, Amlodipine may increase the arrhythmogenic activities of Cicletanine.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Amlodipine can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Amlodipine.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Amlodipine.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Amlodipine.]
[J01DB09, cephradine, The metabolism of Amlodipine can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Amlodipine can be increased when combined with Deflazacort.]
[N02CC08, lasmiditan, Lasmiditan may increase the bradycardic activities of Amlodipine.]
[N03AX25, cenobamate, The metabolism of Amlodipine can be increased when combined with Cenobamate.]
[J05AE05, amprenavir, The metabolism of Amlodipine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Amlodipine.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Amlodipine.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Amlodipine.]
[M01AH02, rofecoxib, The metabolism of Amlodipine can be increased when combined with Rofecoxib.]
[C08CA16, clevidipine, The metabolism of Amlodipine can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, Amlodipine may increase the arrhythmogenic activities of Dronedarone.]
[C02AA06, methoserpidine, Amlodipine may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Amlodipine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Amlodipine is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Amlodipine.]
[D07XB03, fluprednidene, The metabolism of Amlodipine can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, Droxicam may decrease the antihypertensive activities of Amlodipine.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Amlodipine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the antihypertensive activities of Amlodipine.]
[C08CA17, levamlodipine, Amlodipine may increase the hypotensive activities of Levamlodipine.]
[L04AC19, satralizumab, The serum concentration of Amlodipine can be decreased when it is combined with Satralizumab.]
[L01EX23, pralsetinib, The metabolism of Amlodipine can be increased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, The metabolism of Amlodipine can be increased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the hypotensive activities of Amlodipine.]
[N02BA07, ethenzamide, Ethenzamide may decrease the antihypertensive activities of Amlodipine.]
[N06BX18, vinpocetine, Amlodipine may increase the arrhythmogenic activities of Vinpocetine.]
[M01AB08, etodolac, Etodolac may decrease the antihypertensive activities of Amlodipine.]
[M02AA06, etofenamate, Etofenamate may decrease the antihypertensive activities of Amlodipine.]
[B06AC06, berotralstat, The metabolism of Amlodipine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Amlodipine can be decreased when combined with Lonafarnib.]
[M09AA01, hydroquinine, Amlodipine may increase the arrhythmogenic activities of Hydroquinine.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Amlodipine.]
[P03AX07, abametapir, The serum concentration of Amlodipine can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Amlodipine is combined with Vericiguat.]
[M01AE05, fenbufen, Fenbufen may decrease the antihypertensive activities of Amlodipine.]
[C01CA19, fenoldopam, Amlodipine may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Amlodipine.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Amlodipine.]
[R03BA03, flunisolide, The metabolism of Amlodipine can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Amlodipine can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Amlodipine.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Amlodipine.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Amlodipine.]
[H04AA02, dasiglucagon, Amlodipine may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Amlodipine can be increased when it is combined with Cimetidine.]
[N07CA02, cinnarizine, Amlodipine may increase the arrhythmogenic activities of Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Amlodipine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Amlodipine can be decreased when combined with Ciprofloxacin.]
[C03DA05, finerenone, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Finerenone.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Amlodipine is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Mobocertinib.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the antihypertensive activities of Amlodipine.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Gliquidone.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Amlodipine.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium glubionate anhydrous.]
[N06AX25, St. John's wort extract, The metabolism of Amlodipine can be increased when combined with St. John's Wort.]
[C10AB01, clofibrate, The metabolism of Amlodipine can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Amlodipine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Amlodipine.]
[S01EA04, clonidine, Clonidine may increase the atrioventricular blocking (AV block) activities of Amlodipine.]
[C01EB24, mavacamten, The metabolism of Amlodipine can be increased when combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Amlodipine.]
[N05AH02, clozapine, The metabolism of Amlodipine can be increased when combined with Clozapine.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Amlodipine can be increased when combined with Somatrogon.]
[C02KB01, metyrosine, Amlodipine may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, Proquazone may decrease the antihypertensive activities of Amlodipine.]
[C01BA13, hydroquinidine, Amlodipine may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Amlodipine.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Amlodipine.]
[A04AA03, tropisetron, Amlodipine may increase the arrhythmogenic activities of Tropisetron.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Amlodipine.]
[A10BX03, nateglinide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the antihypertensive activities of Amlodipine.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glargine.]
[J01FA15, telithromycin, The risk or severity of adverse effects can be increased when Telithromycin is combined with Amlodipine.]
[B01AC10, indobufen, Indobufen may decrease the antihypertensive activities of Amlodipine.]
[M01AH03, valdecoxib, Valdecoxib may decrease the antihypertensive activities of Amlodipine.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Amlodipine.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Amlodipine.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Amlodipine.]
[M01AH04, parecoxib, Parecoxib may decrease the antihypertensive activities of Amlodipine.]
[J02AC02, itraconazole, The metabolism of Amlodipine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Bemiparin.]
[M01AA06, kebuzone, Kebuzone may decrease the antihypertensive activities of Amlodipine.]
[L01EA01, imatinib, The serum concentration of Amlodipine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Amlodipine can be decreased when combined with Posaconazole.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Amlodipine.]
[S01EE03, bimatoprost, Amlodipine may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Amlodipine may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Amlodipine.]
[N03AX09, lamotrigine, Amlodipine may increase the arrhythmogenic activities of Lamotrigine.]
[S01BA03, cortisone, The metabolism of Amlodipine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Amlodipine.]
[M01AB09, lonazolac, Lonazolac may decrease the antihypertensive activities of Amlodipine.]
[M02AA31, loxoprofen, Loxoprofen may decrease the antihypertensive activities of Amlodipine.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Amlodipine.]
[A06AD01, magnesium carbonate, The risk or severity of hypotension can be increased when Magnesium carbonate is combined with Amlodipine.]
[C08CA11, manidipine, Amlodipine may increase the arrhythmogenic activities of Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Amlodipine.]
[C07AA14, mepindolol, The risk or severity of bradycardia can be increased when Amlodipine is combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Amlodipine can be increased when combined with Meprednisone.]
[C01EB10, adenosine, Amlodipine may increase the arrhythmogenic activities of Adenosine.]
[C04AX01, cyclandelate, Amlodipine may increase the arrhythmogenic activities of Cyclandelate.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Amlodipine.]
[C03DA04, eplerenone, Amlodipine may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, Amlodipine may increase the arrhythmogenic activities of Melperone.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Amlodipine can be increased when combined with Cyclophosphamide.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Amlodipine.]
[S01XA18, cyclosporine, The metabolism of Amlodipine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Amlodipine.]
[C09AA13, moexipril, Amlodipine may increase the hypotensive activities of Moexipril.]
[M02AA02, mofebutazone, Mofebutazone may decrease the antihypertensive activities of Amlodipine.]
[M01AX22, morniflumate, Morniflumate may decrease the antihypertensive activities of Amlodipine.]
[C03XA02, conivaptan, The metabolism of Amlodipine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Amlodipine.]
[G04BE09, vardenafil, Vardenafil may increase the antihypertensive activities of Amlodipine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the antihypertensive activities of Amlodipine.]
[G03XA01, danazol, The metabolism of Amlodipine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Amlodipine.]
[C02CC04, debrisoquin, Amlodipine may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Amlodipine is combined with Nabilone.]
[M01AX01, nabumetone, Nabumetone may decrease the antihypertensive activities of Amlodipine.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Amlodipine.]
[N06AX06, nefazodone, The metabolism of Amlodipine can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Amlodipine.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Amlodipine.]
[M03AC11, cisatracurium, Amlodipine may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Amlodipine.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Amlodipine.]
[A07EC03, olsalazine, Olsalazine may decrease the antihypertensive activities of Amlodipine.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Amlodipine.]
[C01AA07, deslanoside, Amlodipine may increase the arrhythmogenic activities of Deslanoside.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Amlodipine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the antihypertensive activities of Amlodipine.]
[N03AF02, oxcarbazepine, The metabolism of Amlodipine can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Amlodipine can be increased when combined with Dexamethasone.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Amlodipine.]
[B01AC04, clopidogrel, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amlodipine.]
[C01DA05, pentaerythritol tetranitrate, Amlodipine may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Amlodipine.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Amlodipine.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Diclofenamide.]
[S01BC03, diclofenac, Diclofenac may decrease the antihypertensive activities of Amlodipine.]
[J01CF01, dicloxacillin, The metabolism of Amlodipine can be increased when combined with Dicloxacillin.]
[C02DG01, pinacidil, Amlodipine may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, Amlodipine may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Amlodipine is combined with Pipamperone.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Amlodipine.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Amlodipine.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Amlodipine.]
[D07XC04, diflucortolone, The metabolism of Amlodipine can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, Diflunisal may decrease the antihypertensive activities of Amlodipine.]
[C01AA04, digitoxin, Amlodipine may increase the arrhythmogenic activities of Digitoxin.]
[C01AA05, digoxin, Amlodipine may increase the arrhythmogenic activities of Digoxin.]
[C02DB01, dihydralazine, Amlodipine may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may decrease the antihypertensive activities of Amlodipine.]
[N02CA01, dihydroergotamine, The risk or severity of hypotension can be increased when Dihydroergotamine is combined with Amlodipine.]
[J05AE08, atazanavir, The metabolism of Amlodipine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Amlodipine.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Amlodipine.]
[C08DB01, diltiazem, Diltiazem may increase the arrhythmogenic activities of Amlodipine.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Amlodipine.]
[N02BB04, propyphenazone, Propyphenazone may decrease the antihypertensive activities of Amlodipine.]
[M01AB14, proglumetacin, Proglumetacin may decrease the antihypertensive activities of Amlodipine.]
[C09AA06, quinapril, Amlodipine may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Amlodipine.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Amlodipine.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Amlodipine.]
[S01XA23, sirolimus, Amlodipine may increase the immunosuppressive activities of Sirolimus.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Amlodipine.]
[C01BA03, disopyramide, Disopyramide may increase the arrhythmogenic activities of Amlodipine.]
[S02AA12, rifamycin SV, The metabolism of Amlodipine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Amlodipine can be increased when combined with Rifapentine.]
[N05AX08, risperidone, Amlodipine may increase the hypotensive activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Amlodipine.]
[L01EX01, sunitinib, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Amlodipine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Tolvaptan.]
[G04BE08, tadalafil, Amlodipine may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, Ketorolac may decrease the antihypertensive activities of Amlodipine.]
[C02KX02, ambrisentan, Amlodipine may increase the hypotensive activities of Ambrisentan.]
[N02BA06, salsalate, Salsalate may decrease the antihypertensive activities of Amlodipine.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Amlodipine.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Amlodipine.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Amlodipine.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Amlodipine.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Amlodipine.]
[N06AA12, doxepin, The risk or severity of hypotension can be increased when Doxepin is combined with Amlodipine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Amlodipine.]
[N01AB08, sevoflurane, The risk or severity of hypotension can be increased when Sevoflurane is combined with Amlodipine.]
[N05AD08, droperidol, The risk or severity of hypotension can be increased when Droperidol is combined with Amlodipine.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be increased when it is combined with Amlodipine.]
[V03AG05, sodium phosphate, Sodium phosphate, monobasic may increase the hyperkalemic activities of Amlodipine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Amlodipine.]
[C09AA11, spirapril, Amlodipine may increase the hypotensive activities of Spirapril.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Amlodipine.]
[C07AB13, talinolol, Amlodipine may increase the arrhythmogenic activities of Talinolol.]
[H01AA01, corticotropin, The metabolism of Amlodipine can be increased when combined with Corticotropin.]
[M01AC02, tenoxicam, Tenoxicam may decrease the antihypertensive activities of Amlodipine.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Terazosin is combined with Amlodipine.]
[D01BA02, terbinafine, The metabolism of Amlodipine can be increased when combined with Terbinafine.]
[G04BD05, terodiline, Amlodipine may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, Amlodipine may increase the arrhythmogenic activities of Tertatolol.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Amlodipine.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Amlodipine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the antihypertensive activities of Amlodipine.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Amlodipine.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Amlodipine.]
[N03AX11, topiramate, The metabolism of Amlodipine can be increased when combined with Topiramate.]
[C03CA04, torsemide, Torasemide may increase the hypotensive activities of Amlodipine.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Amlodipine.]
[C09AA10, trandolapril, Amlodipine may increase the hypotensive activities of Trandolapril.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Amlodipine.]
[C02CA06, urapidil, The risk or severity of hypotension can be increased when Urapidil is combined with Amlodipine.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Amlodipine.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Amlodipine.]
[S01GA03, xylometazoline, Amlodipine may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Amlodipine may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Amlodipine.]
[C09AA15, zofenopril, Amlodipine may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, Zomepirac may decrease the antihypertensive activities of Amlodipine.]
[N03AX15, zonisamide, Amlodipine may increase the arrhythmogenic activities of Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glulisine.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Amlodipine.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Amlodipine.]
[C01BG01, moricizine, Amlodipine may increase the arrhythmogenic activities of Moricizine.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Amlodipine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Amlodipine.]
[N02CA02, ergotamine, The metabolism of Amlodipine can be decreased when combined with Ergotamine.]
[C01DA13, erythrityl tetranitrate, Amlodipine may increase the vasodilatory activities of Erythrityl tetranitrate.]
[S01AA17, erythromycin, The risk or severity of adverse effects can be increased when Erythromycin is combined with Amlodipine.]
[R03BA09, fluticasone furoate, The metabolism of Amlodipine can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Amlodipine can be increased when combined with Fluticasone.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Amlodipine.]
[V03AF05, amifostine, Amlodipine may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Amlodipine.]
[N03AD01, ethosuximide, Amlodipine may increase the arrhythmogenic activities of Ethosuximide.]
[M01AC06, meloxicam, Meloxicam may decrease the antihypertensive activities of Amlodipine.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Amlodipine.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Amlodipine.]
[C01BA05, ajmaline, Amlodipine may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, Amlodipine may increase the immunosuppressive activities of Tacrolimus.]
[R06AX12, terfenadine, The metabolism of Amlodipine can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Amlodipine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, Amlodipine may increase the arrhythmogenic activities of Tocainide.]
[C01BC08, encainide, Amlodipine may increase the arrhythmogenic activities of Encainide.]
[C08CA02, felodipine, Amlodipine may increase the arrhythmogenic activities of Felodipine.]
[C08EA01, fendiline, Amlodipine may increase the arrhythmogenic activities of Fendiline.]
[M01AE04, fenoprofen, Fenoprofen may decrease the antihypertensive activities of Amlodipine.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Amlodipine.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Amlodipine.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Amlodipine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Clofarabine.]
[C01BC04, flecainide, Amlodipine may increase the arrhythmogenic activities of Flecainide.]
[N02BG04, floctafenine, Floctafenine may decrease the antihypertensive activities of Amlodipine.]
[J01CF05, floxacillin, The metabolism of Amlodipine can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Amlodipine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, Amlodipine may increase the arrhythmogenic activities of Flunarizine.]
[D07AC08, fluocinonide, The metabolism of Amlodipine can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Amlodipine.]
[H02AB03, fluocortolone, The metabolism of Amlodipine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Amlodipine can be increased when combined with Ethanol.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Amlodipine.]
[N05AF01, flupenthixol, The risk or severity of hypotension can be increased when Flupentixol is combined with Amlodipine.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the antihypertensive activities of Amlodipine.]
[N05AG01, fluspirilene, Amlodipine may increase the arrhythmogenic activities of Fluspirilene.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Amlodipine.]
[M03AA01, alcuronium, Amlodipine may increase the neuromuscular blocking activities of Alcuronium.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Amlodipine.]
[J05AE10, darunavir, The metabolism of Amlodipine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Amlodipine may increase the hypotensive activities of Furosemide.]
[N06DA04, galantamine, Amlodipine may increase the bradycardic activities of Galantamine.]
[M03AC02, gallamine, Amlodipine may increase the neuromuscular blocking activities of Gallamine.]
[C08DA02, gallopamil, Amlodipine may increase the arrhythmogenic activities of Gallopamil.]
[N03AA04, barbexaclone, The metabolism of Amlodipine can be increased when combined with Barbexaclone.]
[N04BC06, cabergoline, Cabergoline may decrease the antihypertensive activities of Amlodipine.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Liraglutide.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, Amlodipine may increase the arrhythmogenic activities of Methsuximide.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Amlodipine.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glipizide.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Amlodipine.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Amlodipine.]
[C05AE01, nitroglycerin, Amlodipine may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, Dofetilide may increase the arrhythmogenic activities of Amlodipine.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Doxazosin is combined with Amlodipine.]
[C07AB09, esmolol, Esmolol may increase the arrhythmogenic activities of Amlodipine.]
[C09AA09, fosinopril, Amlodipine may increase the hypotensive activities of Fosinopril.]
[D01BA01, griseofulvin, The metabolism of Amlodipine can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Amlodipine may increase the hypotensive activities of Guanethidine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Haloperidol.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Amlodipine.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Amlodipine.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin aspart.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Heparin.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Amlodipine.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Amlodipine.]
[A07EC02, mesalamine, Mesalazine may decrease the antihypertensive activities of Amlodipine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Amlodipine.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Amlodipine.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Amlodipine.]
[C08CA10, nilvadipine, Amlodipine may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Amlodipine may increase the arrhythmogenic activities of Nimesulide.]
[C02DB02, hydralazine, Amlodipine may increase the hypotensive activities of Hydralazine.]
[S02BA01, hydrocortisone, The metabolism of Amlodipine can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Amlodipine.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Amlodipine.]
[A12BA02, potassium citrate, Potassium citrate may increase the hyperkalemic activities of Amlodipine.]
[G04BD06, propiverine, The risk or severity of hypotension can be increased when Propiverine is combined with Amlodipine.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Amlodipine can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Amlodipine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the antihypertensive activities of Amlodipine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Amlodipine.]
[L01AA06, ifosfamide, The metabolism of Amlodipine can be increased when combined with Ifosfamide.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Amlodipine.]
[N06AA02, imipramine, The risk or severity of hypotension can be increased when Imipramine is combined with Amlodipine.]
[L01CD01, paclitaxel, The metabolism of Amlodipine can be increased when combined with Paclitaxel.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Tizanidine.]
[S01BC01, indomethacin, Indomethacin may decrease the antihypertensive activities of Amlodipine.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Indoramin is combined with Amlodipine.]
[N06AX17, milnacipran, The metabolism of Amlodipine can be decreased when combined with Milnacipran.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Sitagliptin.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Amlodipine can be increased when combined with Cerivastatin.]
[C07AA01, alprenolol, Amlodipine may increase the arrhythmogenic activities of Alprenolol.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Amlodipine.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Amlodipine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Amlodipine.]
[S01EC03, dorzolamide, Amlodipine may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Amlodipine.]
[C09AA16, imidapril, Amlodipine may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Amlodipine.]
[J04AC01, isoniazid, The metabolism of Amlodipine can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Amlodipine.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Amlodipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Amlodipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Amlodipine.]
[L04AC07, tocilizumab, The metabolism of Amlodipine can be increased when combined with Tocilizumab.]
[C02KD01, ketanserin, Amlodipine may increase the hypotensive activities of Ketanserin.]
[H02CA04, levoketoconazole, The metabolism of Amlodipine can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Amlodipine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of hypotension can be increased when Olanzapine is combined with Amlodipine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the antihypertensive activities of Amlodipine.]
[V03AC03, deferasirox, The metabolism of Amlodipine can be increased when combined with Deferasirox.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Amlodipine.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Amlodipine.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the antihypertensive activities of Amlodipine.]
[C07AG01, labetalol, The risk or severity of bradycardia can be increased when Amlodipine is combined with Labetalol.]
[C02AA05, deserpidine, Amlodipine may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Amlodipine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Amlodipine.]
[N03AX18, lacosamide, Amlodipine may increase the bradycardic activities of Lacosamide.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Amlodipine is combined with Etacrynic acid.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Amlodipine is combined with Levodopa.]
[S02DA01, lidocaine, Lidocaine may increase the arrhythmogenic activities of Amlodipine.]
[C08EX01, lidoflazine, Amlodipine may increase the arrhythmogenic activities of Lidoflazine.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amlodipine is combined with Amiloride.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Amlodipine.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Amlodipine.]
[A07DA03, loperamide, Amlodipine may increase the arrhythmogenic activities of Loperamide.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium pangamate.]
[C10AA02, lovastatin, The metabolism of Amlodipine can be decreased when combined with Lovastatin.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Amlodipine.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Amlodipine.]
[A12CC10, magnesium oxide, The risk or severity of hypotension can be increased when Magnesium oxide is combined with Amlodipine.]
[V04CC02, magnesium sulfate, Amlodipine may increase the arrhythmogenic activities of Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Amlodipine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Amlodipine is combined with Mannitol.]
[C02BB01, mecamylamine, Amlodipine may increase the hypotensive activities of Mecamylamine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the antihypertensive activities of Amlodipine.]
[C01AA08, medigoxin, Amlodipine may increase the arrhythmogenic activities of Metildigoxin.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Amlodipine.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Dalteparin.]
[N05CH01, melatonin, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Melatonin.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Amlodipine.]
[N03AA01, mephobarbital, The metabolism of Amlodipine can be increased when combined with Methylphenobarbital.]
[L02BG01, aminoglutethimide, The metabolism of Amlodipine can be increased when combined with Aminoglutethimide.]
[N05AX13, paliperidone, The risk or severity of hypotension can be increased when Paliperidone is combined with Amlodipine.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Amlodipine.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Metformin.]
[H01CB03, lanreotide, Amlodipine may increase the bradycardic activities of Lanreotide.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Amlodipine.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Methazolamide.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Amlodipine.]
[H03BB02, methimazole, The metabolism of Amlodipine can be decreased when combined with Methimazole.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Amlodipine.]
[N02BG08, ziconotide, Amlodipine may increase the arrhythmogenic activities of Ziconotide.]
[N05AA02, methotrimeprazine, The risk or severity of hypotension can be increased when Methotrimeprazine is combined with Amlodipine.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Amlodipine.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Amlodipine.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Methyclothiazide.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Amlodipine.]
[C02AB01, methyldopa, Amlodipine may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Amlodipine.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Amlodipine.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Amlodipine.]
[H02AB04, methylprednisolone, The metabolism of Amlodipine can be increased when combined with Methylprednisolone.]
[N02CA04, methysergide, Methysergide may decrease the antihypertensive activities of Amlodipine.]
[C03BA08, metolazone, Amlodipine may increase the hypotensive activities of Metolazone.]
[C07AB02, metoprolol, Metoprolol may increase the arrhythmogenic activities of Amlodipine.]
[V04CD01, metyrapone, The metabolism of Amlodipine can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Amlodipine.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Amlodipine.]
[S02AA13, miconazole, The metabolism of Amlodipine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the antihypertensive activities of Amlodipine.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Parnaparin.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Amlodipine.]
[G03XB01, mifepristone, The metabolism of Amlodipine can be increased when combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Amlodipine.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Amlodipine.]
[L01XX23, mitotane, The metabolism of Amlodipine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Amlodipine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amlodipine.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Amlodipine.]
[C01BD01, amiodarone, The metabolism of Amlodipine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of hypotension can be increased when Amitriptyline is combined with Amlodipine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Amlodipine.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Ammonium chloride.]
[M03AC03, vecuronium, Amlodipine may increase the neuromuscular blocking activities of Vecuronium.]
[N05CA02, amobarbital, The metabolism of Amlodipine can be increased when combined with Amobarbital.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Amlodipine is combined with Silodosin.]
[N06AA17, amoxapine, The risk or severity of hypotension can be increased when Amoxapine is combined with Amlodipine.]
[N03AB05, fosphenytoin, The metabolism of Amlodipine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Amlodipine may increase the arrhythmogenic activities of Nadolol.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Amlodipine.]
[J01CF06, nafcillin, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Nafcillin.]
[V03AB15, naloxone, The metabolism of Amlodipine can be decreased when combined with Naloxone.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Amlodipine.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Amlodipine.]
[M02AA12, naproxen, Naproxen may decrease the antihypertensive activities of Amlodipine.]
[A10BG01, troglitazone, The metabolism of Amlodipine can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Amlodipine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Amlodipine.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Amlodipine.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Repaglinide.]
[C01CX08, levosimendan, Amlodipine may increase the arrhythmogenic activities of Levosimendan.]
[N05AX14, iloperidone, The risk or severity of hypotension can be increased when Iloperidone is combined with Amlodipine.]
[J02AA01, amphotericin B, Amlodipine may decrease the nephrotoxic activities of Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Amlodipine can be decreased when combined with Desvenlafaxine.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Amlodipine.]
[C08CA04, nicardipine, Amlodipine may increase the arrhythmogenic activities of Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypotension can be increased when Nicergoline is combined with Amlodipine.]
[C08CA05, nifedipine, Amlodipine may increase the arrhythmogenic activities of Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the antihypertensive activities of Amlodipine.]
[V03AB22, amyl nitrite, Amlodipine may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, Amlodipine may increase the arrhythmogenic activities of Nimodipine.]
[C08CA07, nisoldipine, Amlodipine may increase the arrhythmogenic activities of Nisoldipine.]
[C08CA08, nitrendipine, Amlodipine may increase the arrhythmogenic activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Amlodipine is combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Nitrofurantoin.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Amlodipine is combined with Pramipexole.]
[C02DD01, nitroprusside, Amlodipine may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Amlodipine.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Amlodipine.]
[C02KX01, bosentan, Amlodipine may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, The risk or severity of hypotension can be increased when Nortriptyline is combined with Amlodipine.]
[G02CA02, nylidrin, Amlodipine may increase the arrhythmogenic activities of Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Reviparin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Amlodipine.]
[A02BC01, omeprazole, The metabolism of Amlodipine can be increased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Amlodipine.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Amlodipine.]
[G04CA02, tamsulosin, The risk or severity of hypotension can be increased when Tamsulosin is combined with Amlodipine.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Amlodipine.]
[C07AA02, oxprenolol, Amlodipine may increase the arrhythmogenic activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Amlodipine.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Amlodipine can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the antihypertensive activities of Amlodipine.]
[N05AH05, asenapine, The risk or severity of hypotension can be increased when Asenapine is combined with Amlodipine.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Danaparoid.]
[M03AC01, pancuronium, Amlodipine may increase the neuromuscular blocking activities of Pancuronium.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Papaverine.]
[H02AB05, paramethasone, The metabolism of Amlodipine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Amlodipine.]
[C07AA23, penbutolol, The risk or severity of bradycardia can be increased when Amlodipine is combined with Penbutolol.]
[N05AG03, penfluridol, Amlodipine may increase the arrhythmogenic activities of Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Amlodipine can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Amlodipine.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Amlodipine.]
[C08EX02, perhexiline, Amlodipine may increase the arrhythmogenic activities of Perhexiline.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Amlodipine.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Amlodipine can be increased when combined with Phenobarbital.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Amlodipine.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Amlodipine.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Amlodipine.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Phentolamine is combined with Amlodipine.]
[M02AA01, phenylbutazone, The metabolism of Amlodipine can be increased when combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Amlodipine is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Amlodipine.]
[N03AB02, phenytoin, The metabolism of Amlodipine can be increased when combined with Phenytoin.]
[C08CX01, mibefradil, Amlodipine may increase the arrhythmogenic activities of Mibefradil.]
[C07AA03, pindolol, The risk or severity of bradycardia can be increased when Amlodipine is combined with Pindolol.]
[J05AE01, saquinavir, The metabolism of Amlodipine can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, Amlodipine may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, Piroxicam may decrease the antihypertensive activities of Amlodipine.]
[N02CX01, pizotyline, The risk or severity of hypotension can be increased when Pizotifen is combined with Amlodipine.]
[J05AG02, delavirdine, The metabolism of Amlodipine can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Rosiglitazone.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amlodipine.]
[C03AA05, polythiazide, The therapeutic efficacy of Amlodipine can be increased when used in combination with Polythiazide.]
[J05AE03, ritonavir, The metabolism of Amlodipine can be decreased when combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Saxagliptin.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Amlodipine.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Amlodipine.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin lispro.]
[C07AB01, practolol, Amlodipine may increase the arrhythmogenic activities of Practolol.]
[C01BA08, prajmaline, Amlodipine may increase the arrhythmogenic activities of Prajmaline.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Amlodipine.]
[S03BA02, prednisolone, The metabolism of Amlodipine can be increased when combined with Prednisolone.]
[C01DX02, prenylamine, Amlodipine may increase the arrhythmogenic activities of Prenylamine.]
[P01BA03, primaquine, The metabolism of Amlodipine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Amlodipine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Amlodipine can be increased when combined with Probenecid.]
[C01BA02, procainamide, Amlodipine may increase the arrhythmogenic activities of Procainamide.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Amlodipine.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Amlodipine.]
[N05AA03, promazine, The risk or severity of hypotension can be increased when Promazine is combined with Amlodipine.]
[C01BC03, propafenone, Amlodipine may increase the arrhythmogenic activities of Propafenone.]
[N05AC01, periciazine, The risk or severity of hypotension can be increased when Periciazine is combined with Amlodipine.]
[N05CM06, propiomazine, The risk or severity of hypotension can be increased when Propiomazine is combined with Amlodipine.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Amlodipine.]
[C07AA05, propranolol, Amlodipine may increase the arrhythmogenic activities of Propranolol.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Amlodipine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Amlodipine.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Amlodipine.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Amlodipine.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Amlodipine.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Amlodipine.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Amlodipine.]
[C01BA01, quinidine, Amlodipine may increase the arrhythmogenic activities of Quinidine.]
[P01BC01, quinine, The metabolism of Amlodipine can be increased when combined with Quinine.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Amlodipine.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Amlodipine.]
[J04AB02, rifampin, The metabolism of Amlodipine can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Amlodipine.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Amlodipine.]
[J01FA06, roxithromycin, The risk or severity of adverse effects can be increased when Roxithromycin is combined with Amlodipine.]
[N02BA05, salicylamide, Salicylamide may decrease the antihypertensive activities of Amlodipine.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the antihypertensive activities of Amlodipine.]
[S01BC08, salicylic acid, Salicylic acid may decrease the antihypertensive activities of Amlodipine.]
[N05CA06, secobarbital, The metabolism of Amlodipine can be increased when combined with Secobarbital.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Amlodipine.]
[L01FA03, obinutuzumab, Amlodipine may increase the hypotensive activities of Obinutuzumab.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Amlodipine.]
[C07AA07, sotalol, Amlodipine may increase the arrhythmogenic activities of Sotalol.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Amlodipine is combined with Spironolactone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Amlodipine can be increased when combined with Hydrocortisone butyrate.]
[S02DA03, antipyrine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Antipyrine is combined with Perindopril.]
[B01AD01, streptokinase, The risk or severity of angioedema can be increased when Streptokinase is combined with Perindopril.]
[J01GA01, streptomycin, Perindopril may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Perindopril.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01CG01, sulbactam, Perindopril may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Sulfamethoxazole.]
[M01AB02, sulindac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulindac is combined with Perindopril.]
[M01AX04, apazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azapropazone is combined with Perindopril.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Perindopril.]
[B01AE07, dabigatran etexilate, Perindopril may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Perindopril.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Perindopril.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Perindopril is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Perindopril.]
[N05AB08, thioproperazine, Thioproperazine may decrease the antihypertensive activities of Perindopril.]
[N05AC02, thioridazine, Thioridazine may decrease the antihypertensive activities of Perindopril.]
[B02AB01, aprotinin, Aprotinin may decrease the antihypertensive activities of Perindopril.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Perindopril.]
[N05AL03, tiapride, Perindopril may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01ED01, timolol, Timolol may increase the hypotensive activities of Perindopril.]
[P01AB02, tinidazole, Perindopril may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Perindopril may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Perindopril may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may decrease the antihypertensive activities of Perindopril.]
[V04CA01, tolbutamide, Perindopril may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tolmetin is combined with Perindopril.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Perindopril.]
[N06AX05, trazodone, Trazodone may decrease the antihypertensive activities of Perindopril.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Perindopril.]
[C03DB02, triamterene, The risk or severity of hyperkalemia can be increased when Triamterene is combined with Perindopril.]
[N05CD05, triazolam, Perindopril may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Trichlormethiazide.]
[A16AX12, trientine, Perindopril may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may decrease the antihypertensive activities of Perindopril.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Trimebutine.]
[S01ED04, metipranolol, Perindopril may increase the hypotensive activities of Metipranolol.]
[N03AC02, trimethadione, The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Perindopril.]
[C02BA01, trimethaphan, Perindopril may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may increase the hyperkalemic activities of Perindopril.]
[N06AA06, trimipramine, Trimipramine may decrease the antihypertensive activities of Perindopril.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Perindopril.]
[C09CA09, azilsartan medoxomil, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Perindopril may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Perindopril may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Perindopril may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The risk or severity of angioedema can be increased when Linagliptin is combined with Perindopril.]
[B01AD04, urokinase, The risk or severity of angioedema can be increased when Urokinase is combined with Perindopril.]
[S01AA28, vancomycin, Perindopril may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Perindopril may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Perindopril may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Perindopril.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Verapamil is combined with Perindopril.]
[N06AX09, viloxazine, Perindopril may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[C04AX07, vincamine, Perindopril may increase the hypotensive activities of Vincamine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[B01AA03, warfarin, Perindopril may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Perindopril.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, Zuclopenthixol may decrease the antihypertensive activities of Perindopril.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[M05BA05, tiludronic acid, Perindopril may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the antihypertensive activities of Perindopril.]
[A02BC04, rabeprazole, Perindopril may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Perindopril.]
[G03AC10, drospirenone, Perindopril may increase the hyperkalemic activities of Drospirenone.]
[V03AC02, deferiprone, Perindopril may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The therapeutic efficacy of Perindopril can be decreased when used in combination with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Perindopril may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Perindopril may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Perindopril may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may increase the hypotensive activities of Perindopril.]
[L01FA01, rituximab, Perindopril may increase the hypotensive activities of Rituximab.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Perindopril.]
[M01CB03, auranofin, Perindopril may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Perindopril may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Perindopril may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Perindopril is combined with Azathioprine.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G04BE10, avanafil, Perindopril may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Perindopril.]
[A08AA11, lorcaserin, Perindopril may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Perindopril.]
[L02BB04, enzalutamide, Perindopril may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Perindopril.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Perindopril.]
[D02BA02, octinoxate, Perindopril may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Perindopril.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Perindopril.]
[C08CA13, lercanidipine, Lercanidipine may increase the hypotensive activities of Perindopril.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Perindopril.]
[V09IX04, fluorodeoxyglucose F18, Perindopril may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Perindopril.]
[G04BE03, sildenafil, Sildenafil may increase the antihypertensive activities of Perindopril.]
[V08CA11, gadofosveset, Perindopril may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Perindopril may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Bencyclane.]
[A10BH04, alogliptin, The risk or severity of angioedema can be increased when Alogliptin is combined with Perindopril.]
[A16AX09, glycerol phenylbutyrate, Perindopril may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, Perindopril may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Benorilate is combined with Perindopril.]
[A10BK02, canagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Perindopril.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin detemir.]
[L03AA12, ancestim, Perindopril may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Celecoxib is combined with Perindopril.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Perindopril.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Everolimus is combined with Perindopril.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Benzydamine is combined with Perindopril.]
[L01EE01, trametinib, Perindopril may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Perindopril may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Perindopril may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Perindopril may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Perindopril may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Perindopril may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Perindopril may increase the hypotensive activities of Macitentan.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Perindopril.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J05AP08, sofosbuvir, Perindopril may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Perindopril.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Perindopril.]
[C07AB04, acebutolol, Perindopril may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, Perindopril may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Perindopril may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Perindopril may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Perindopril.]
[V03AB34, fomepizole, Perindopril may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Perindopril.]
[A10BK03, empagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Perindopril.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Perindopril.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01EE02, unoprostone, Perindopril may increase the hypotensive activities of Unoprostone.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AA04, acepromazine, Acepromazine may decrease the antihypertensive activities of Perindopril.]
[S03AA06, gentamicin, Perindopril may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Perindopril may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Perindopril.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AX16, brexpiprazole, Brexpiprazole may decrease the antihypertensive activities of Perindopril.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Perindopril.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Perindopril.]
[M02AA25, aceclofenac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aceclofenac is combined with Perindopril.]
[M01AB11, acemetacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Perindopril.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin degludec.]
[V03AB37, idarucizumab, Perindopril may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Perindopril.]
[L01XG03, ixazomib, Perindopril may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Perindopril may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Perindopril.]
[M04AB05, lesinurad, Perindopril may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Alminoprofen is combined with Perindopril.]
[N02BA02, aloxiprin, The risk or severity of renal failure can be increased when Aloxiprin is combined with Perindopril.]
[N03AX23, brivaracetam, Perindopril may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Perindopril may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, Bromocriptine may decrease the antihypertensive activities of Perindopril.]
[A02AD05, aluminum magnesium silicate, Perindopril may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Perindopril.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Perindopril.]
[C07AA19, bupranolol, Perindopril may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Perindopril.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Perindopril is combined with Arsenic trioxide.]
[M02AA03, clofezone, Perindopril may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Balsalazide is combined with Perindopril.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Perindopril.]
[A06AH05, naldemedine, Perindopril may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Perindopril may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The risk or severity of angioedema can be increased when Pregabalin is combined with Perindopril.]
[C09AA07, benazepril, The risk or severity of angioedema can be increased when Benazepril is combined with Perindopril.]
[P01CA02, benznidazole, Perindopril may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Perindopril.]
[J05AF06, abacavir, Perindopril may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Perindopril may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Perindopril.]
[J01MA23, delafloxacin, Perindopril may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Perindopril may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Perindopril.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Bopindolol.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Perindopril is combined with Nesiritide.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Canrenone is combined with Perindopril.]
[R03BA02, budesonide, Perindopril may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Perindopril.]
[M01AB07, bumadizone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Bumadizone is combined with Perindopril.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Perindopril.]
[A10BK04, ertugliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Perindopril.]
[R06AX18, acrivastine, Perindopril may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of angioedema can be increased when Perindopril is combined with Captopril.]
[L02BB05, apalutamide, Perindopril may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Perindopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, Perindopril may increase the hypotensive activities of Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may increase the antihypertensive activities of Perindopril.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Perindopril.]
[L04AA37, baricitinib, Perindopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01GB14, plazomicin, Perindopril may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Perindopril may increase the hypotensive activities of Celiprolol.]
[A16AX14, migalastat, Perindopril may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Perindopril may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[D08AE05, chloroxylenol, Perindopril may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Perindopril.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A06AX05, prucalopride, Perindopril may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of angioedema can be increased when Perindopril is combined with Cilazapril.]
[B01AC23, cilostazol, Perindopril may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Perindopril.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Perindopril.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Perindopril.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Perindopril.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C09CA06, candesartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N07XX11, pitolisant, Perindopril may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Perindopril.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[M09AX08, golodirsen, Perindopril may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Perindopril may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Perindopril.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Perindopril.]
[R02AA03, dichlorobenzyl alcohol, Perindopril may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Perindopril may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Perindopril.]
[M01AH02, rofecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Rofecoxib is combined with Perindopril.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Perindopril is combined with Clevidipine.]
[C01BD07, dronedarone, Dronedarone may decrease the antihypertensive activities of Perindopril.]
[V03AE03, lanthanum carbonate, Lanthanum carbonate can cause a decrease in the absorption of Perindopril resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02AA06, methoserpidine, Perindopril may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Perindopril is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Perindopril.]
[M01AC04, droxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Droxicam is combined with Perindopril.]
[V08CA05, mangafodipir, Perindopril may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Perindopril.]
[M02AA27, dexketoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexketoprofen is combined with Perindopril.]
[C08CA17, levamlodipine, Perindopril may increase the hypotensive activities of Levamlodipine.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the antihypertensive activities of Perindopril.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03BA04, chlorthalidone, The risk or severity of hypotension can be increased when Chlorthalidone is combined with Perindopril.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ethenzamide is combined with Perindopril.]
[N02BA03, choline salicylate, The risk or severity of renal failure can be increased when Choline salicylate is combined with Perindopril.]
[N06BX18, vinpocetine, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Perindopril.]
[M02AA06, etofenamate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etofenamate is combined with Perindopril.]
[M01AX25, chondroitin sulfates, Perindopril may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Perindopril.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Perindopril is combined with Vericiguat.]
[M01AE05, fenbufen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Perindopril.]
[C01CA19, fenoldopam, Perindopril may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Perindopril.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Perindopril.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02BG07, flupirtine, Perindopril may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Perindopril.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin human.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Perindopril.]
[H04AA02, dasiglucagon, Perindopril may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Perindopril.]
[S03AA07, ciprofloxacin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Ciprofloxacin.]
[L01XA01, cisplatin, Perindopril may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Perindopril may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Perindopril may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Perindopril may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Perindopril.]
[B01AD11, tenecteplase, The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindopril.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Perindopril is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Perindopril.]
[N03AE01, clonazepam, Perindopril may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Perindopril.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the antihypertensive activities of Perindopril.]
[J01GB12, arbekacin, Perindopril may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[C02KB01, metyrosine, Metyrosine may increase the hypotensive activities of Perindopril.]
[M01AX13, proquazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Proquazone is combined with Perindopril.]
[M04AC01, colchicine, Perindopril may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Perindopril may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Perindopril.]
[A04AA03, tropisetron, Perindopril may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Perindopril.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Imidazole salicylate is combined with Perindopril.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin glargine.]
[B01AC10, indobufen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indobufen is combined with Perindopril.]
[J05AB14, valganciclovir, Perindopril may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Perindopril may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Perindopril may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Perindopril may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Perindopril may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Perindopril may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Perindopril.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Perindopril.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Perindopril.]
[M01AH04, parecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Parecoxib is combined with Perindopril.]
[J02AC02, itraconazole, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Bemiparin.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05BA10, ketazolam, Perindopril may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Kebuzone is combined with Perindopril.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Perindopril.]
[S01EE03, bimatoprost, Perindopril may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Perindopril may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Perindopril.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Perindopril.]
[M01AB09, lonazolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lonazolac is combined with Perindopril.]
[M02AA31, loxoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Loxoprofen is combined with Perindopril.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of angioedema can be increased when Lisinopril is combined with Perindopril.]
[A06AD01, magnesium carbonate, Perindopril may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Perindopril may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Perindopril.]
[C07AA14, mepindolol, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Mepindolol.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Perindopril.]
[C03DA04, eplerenone, Eplerenone may increase the hyperkalemic activities of Perindopril.]
[N05AD03, metylperon, Perindopril may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Perindopril.]
[S01XA18, cyclosporine, Cyclosporine may decrease the antihypertensive activities of Perindopril.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Perindopril.]
[C09AA13, moexipril, The risk or severity of angioedema can be increased when Moexipril is combined with Perindopril.]
[M02AA02, mofebutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mofebutazone is combined with Perindopril.]
[M01AX22, morniflumate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Morniflumate is combined with Perindopril.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Perindopril.]
[G04BE09, vardenafil, Vardenafil may increase the antihypertensive activities of Perindopril.]
[M01AH05, etoricoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etoricoxib is combined with Perindopril.]
[L01AX04, dacarbazine, Perindopril may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Dantrolene.]
[C02CC04, debrisoquin, Perindopril may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Perindopril.]
[M01AX01, nabumetone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Perindopril.]
[N07BB05, nalmefene, Perindopril may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Perindopril.]
[C07AB12, nebivolol, Perindopril may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the antihypertensive activities of Perindopril.]
[C01DX16, nicorandil, Nicorandil may increase the vasodilatory activities of Perindopril.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Perindopril.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Perindopril.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Perindopril.]
[A07EC03, olsalazine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olsalazine is combined with Perindopril.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Perindopril.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Perindopril.]
[V04CH02, indigo carmine, Perindopril may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Perindopril.]
[M01AE12, oxaprozin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Perindopril.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Perindopril.]
[P03AC04, permethrin, Perindopril may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Perindopril may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Perindopril.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Perindopril.]
[R05DA08, pholcodine, Perindopril may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diclofenac is combined with Perindopril.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A03AA07, dicyclomine, Perindopril may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Perindopril may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Perindopril may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Pinaverium.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Perindopril is combined with Pipamperone.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Perindopril.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Perindopril.]
[C08CA03, isradipine, Isradipine may increase the hypotensive activities of Perindopril.]
[D07XC04, diflucortolone, Perindopril may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diflunisal is combined with Perindopril.]
[C01AA05, digoxin, Perindopril may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Perindopril may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may decrease the antihypertensive activities of Perindopril.]
[N02CA01, dihydroergotamine, Dihydroergotamine may decrease the antihypertensive activities of Perindopril.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Perindopril.]
[H03BC01, potassium perchlorate, The risk or severity of hyperkalemia can be increased when Potassium perchlorate is combined with Perindopril.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the hypotensive activities of Perindopril.]
[V03AB09, dimercaprol, Perindopril may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Perindopril.]
[M02AX03, dimethyl sulfoxide, Perindopril may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Propyphenazone is combined with Perindopril.]
[M01AB14, proglumetacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Proglumetacin is combined with Perindopril.]
[C09AA06, quinapril, The risk or severity of angioedema can be increased when Perindopril is combined with Quinapril.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Perindopril.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Perindopril.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Perindopril.]
[C09AA05, ramipril, The risk or severity of angioedema can be increased when Ramipril is combined with Perindopril.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Sirolimus is combined with Perindopril.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Perindopril.]
[S01AX06, resorcinol, Perindopril may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AX08, risperidone, Perindopril may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Perindopril may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Perindopril.]
[C03XA01, tolvaptan, Tolvaptan may increase the hyperkalemic activities of Perindopril.]
[G04BE08, tadalafil, Perindopril may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Perindopril.]
[C02KX02, ambrisentan, Perindopril may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salsalate is combined with Perindopril.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Perindopril.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Perindopril.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Perindopril.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Perindopril.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Perindopril.]
[N06AA12, doxepin, Doxepin may decrease the antihypertensive activities of Perindopril.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Perindopril.]
[N05AD08, droperidol, Droperidol may decrease the antihypertensive activities of Perindopril.]
[A08AA10, sibutramine, Perindopril may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[V03AG05, sodium phosphate, The risk or severity of nephrotoxicity can be increased when Perindopril is combined with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, Perindopril may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk or severity of angioedema can be increased when Perindopril is combined with Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Perindopril.]
[V04CX07, edrophonium, Perindopril may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Perindopril may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Perindopril may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tenoxicam is combined with Perindopril.]
[G04CA03, terazosin, Perindopril may increase the hypotensive activities of Terazosin.]
[G04BD05, terodiline, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Terodiline.]
[C07AA16, tertatolol, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Tertatolol.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Perindopril.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Perindopril.]
[C09AA02, enalapril, The risk or severity of angioedema can be increased when Enalapril is combined with Perindopril.]
[M01AG02, tolfenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tolfenamic acid is combined with Perindopril.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Perindopril.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Perindopril.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Perindopril.]
[C09AA10, trandolapril, The risk or severity of angioedema can be increased when Trandolapril is combined with Perindopril.]
[N05CC01, chloral hydrate, Perindopril may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Perindopril.]
[C02CA06, urapidil, Urapidil may decrease the antihypertensive activities of Perindopril.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Perindopril.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Perindopril.]
[S01GA03, xylometazoline, Xylometazoline may decrease the antihypertensive activities of Perindopril.]
[C08CA12, mepirodipine, Perindopril may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Perindopril.]
[C09AA15, zofenopril, The risk or severity of angioedema can be increased when Perindopril is combined with Zofenopril.]
[M01AB04, zomepirac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Zomepirac is combined with Perindopril.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin glulisine.]
[B01AD03, anistreplase, The risk or severity of angioedema can be increased when Anistreplase is combined with Perindopril.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Perindopril.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Perindopril.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Perindopril.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Perindopril.]
[N02CA02, ergotamine, Ergotamine may decrease the antihypertensive activities of Perindopril.]
[L03AX05, pidotimod, Perindopril may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Perindopril may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Perindopril.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Perindopril.]
[V03AF05, amifostine, Perindopril may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Perindopril.]
[M01AC06, meloxicam, The therapeutic efficacy of Perindopril can be decreased when used in combination with Meloxicam.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Perindopril.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Perindopril.]
[L04AD02, tacrolimus, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Tacrolimus.]
[P01AX07, trimetrexate, Perindopril may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Perindopril may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Perindopril is combined with Sodium aurothiomalate.]
[B05AA05, dextran, Perindopril may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C08CA02, felodipine, Perindopril may increase the hypotensive activities of Felodipine.]
[C08EA01, fendiline, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Fendiline.]
[M01AE04, fenoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenoprofen is combined with Perindopril.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Perindopril.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Perindopril.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Perindopril.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Perindopril.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G04BD02, flavoxate, Perindopril may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Floctafenine is combined with Perindopril.]
[J02AC01, fluconazole, The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Perindopril.]
[J02AX01, flucytosine, Perindopril may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Perindopril may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Flunarizine.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Perindopril.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Perindopril.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AF01, flupenthixol, Flupentixol may decrease the antihypertensive activities of Perindopril.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Flurbiprofen is combined with Perindopril.]
[N05AG01, fluspirilene, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Fluspirilene.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S02AA17, fosfomycin, Perindopril may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L01BC03, tegafur, Perindopril may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Perindopril.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Perindopril.]
[C03CA01, furosemide, The risk or severity of renal failure and hypotension can be increased when Furosemide is combined with Perindopril.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C08DA02, gallopamil, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Gallopamil.]
[S01AD09, ganciclovir, Perindopril may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Perindopril.]
[C10AB04, gemfibrozil, Perindopril may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Perindopril may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Cabergoline may decrease the antihypertensive activities of Perindopril.]
[N03AD03, methsuximide, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Methsuximide.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Perindopril.]
[A10BB07, glipizide, Perindopril may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Perindopril.]
[C05AE01, nitroglycerin, Nitroglycerin may increase the hypotensive activities of Perindopril.]
[C02CA04, doxazosin, Doxazosin may increase the hypotensive activities of Perindopril.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Perindopril.]
[M01CB04, aurothioglucose, Perindopril may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Perindopril may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of angioedema can be increased when Fosinopril is combined with Perindopril.]
[S01EX01, guanethidine, Perindopril may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Perindopril.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Perindopril.]
[N06BX13, idebenone, Perindopril may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin aspart.]
[M04AA01, allopurinol, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Perindopril.]
[C09CA01, losartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Losartan.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Heparin.]
[G03DC01, allylestrenol, Perindopril may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Perindopril.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Perindopril.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Perindopril.]
[C08CA10, nilvadipine, Perindopril may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Perindopril.]
[M01AG01, mefenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mefenamic acid is combined with Perindopril.]
[C01DA05, pentaerythritol tetranitrate, Perindopril may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C02DB02, hydralazine, Perindopril may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Perindopril.]
[S01XA07, aluminum potassium sulfate, The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Perindopril.]
[A12BA02, potassium citrate, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Perindopril.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the antihypertensive activities of Perindopril.]
[B05AA07, hetastarch, Perindopril may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Perindopril.]
[R02AX02, ibuprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ibuprofen is combined with Perindopril.]
[B05XA08, sodium acetate, Perindopril may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Perindopril may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Perindopril.]
[N06AA02, imipramine, Imipramine may decrease the antihypertensive activities of Perindopril.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Perindopril is combined with Paclitaxel.]
[R01AD07, tixocortol, Perindopril may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.]
[L01CE01, topotecan, Perindopril may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[S01BC01, indomethacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Perindopril.]
[C02CA02, indoramin, Indoramin may decrease the antihypertensive activities of Perindopril.]
[A11HA07, inositol, Perindopril may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Perindopril may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Perindopril may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The risk or severity of angioedema can be increased when Sitagliptin is combined with Perindopril.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05CH02, ramelteon, Perindopril may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[A10BH02, vildagliptin, The risk or severity of angioedema can be increased when Vildagliptin is combined with Perindopril.]
[C07AA01, alprenolol, Perindopril may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, The risk or severity of hypotension can be increased when Quinethazone is combined with Perindopril.]
[V03AB01, ipecac, Perindopril may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Perindopril.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Perindopril.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Perindopril.]
[S01EC03, dorzolamide, Perindopril may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Perindopril.]
[C09AA16, imidapril, The risk or severity of angioedema can be increased when Perindopril is combined with Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Perindopril.]
[J04AC01, isoniazid, Perindopril may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Perindopril may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Perindopril.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Perindopril may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Perindopril.]
[S01AA24, kanamycin, Perindopril may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Perindopril may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Perindopril may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Perindopril may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Perindopril.]
[M02AA10, ketoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Perindopril.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Perindopril.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Perindopril.]
[C07AG01, labetalol, Labetalol may increase the hypotensive activities of Perindopril.]
[N04BB01, amantadine, Perindopril may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Perindopril may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Perindopril may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Perindopril is combined with Levodopa.]
[C08EX01, lidoflazine, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Lidoflazine.]
[S01AA21, amikacin, Perindopril may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The risk or severity of hyperkalemia can be increased when Amiloride is combined with Perindopril.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Perindopril.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Perindopril.]
[A07DA03, loperamide, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L01EG01, temsirolimus, The risk or severity of angioedema can be increased when Perindopril is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Perindopril may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Perindopril may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Perindopril.]
[L01BA05, pralatrexate, Perindopril may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Perindopril may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may increase the hypotensive activities of Perindopril.]
[M02AA18, meclofenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Perindopril.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Dalteparin.]
[N06DX01, memantine, Perindopril may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Perindopril.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Perindopril.]
[N01BB03, mepivacaine, Perindopril may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Perindopril may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the antihypertensive activities of Perindopril.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Perindopril.]
[A10BA02, metformin, The risk or severity of lactic acidosis can be increased when Perindopril is combined with Metformin.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Perindopril.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Perindopril.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L01BA04, pemetrexed, Perindopril may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Perindopril.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Methotrimeprazine may decrease the antihypertensive activities of Perindopril.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Perindopril.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Perindopril.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Perindopril may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Perindopril.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Perindopril.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Perindopril.]
[G03EK01, methyltestosterone, Perindopril may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, Methysergide may decrease the antihypertensive activities of Perindopril.]
[A03FA01, metoclopramide, Perindopril may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, The risk or severity of hypotension can be increased when Metolazone is combined with Perindopril.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Perindopril.]
[V04CD01, metyrapone, Perindopril may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Perindopril.]
[N02BB03, aminopyrine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Perindopril.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Parnaparin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Perindopril.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Tinzaparin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Valsartan.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Perindopril.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Perindopril.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Perindopril.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Perindopril.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Perindopril is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the antihypertensive activities of Perindopril.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Perindopril.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Perindopril may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Ammonium chloride.]
[L04AA06, mycophenolic acid, Perindopril may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Perindopril.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Perindopril is combined with Silodosin.]
[N06AA17, amoxapine, Amoxapine may decrease the antihypertensive activities of Perindopril.]
[C07AA12, nadolol, Perindopril may increase the hypotensive activities of Nadolol.]
[J01CA04, amoxicillin, Perindopril may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Perindopril.]
[V03AB15, naloxone, Perindopril may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Perindopril.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Perindopril.]
[M02AA12, naproxen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Perindopril.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Perindopril is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Perindopril.]
[S03AA01, neomycin, Perindopril may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Perindopril.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Perindopril is combined with Levosimendan.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AX14, iloperidone, Iloperidone may decrease the antihypertensive activities of Perindopril.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Perindopril.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[L03AX16, plerixafor, Perindopril may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Perindopril may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Perindopril may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01CE01, inamrinone, Perindopril may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Perindopril.]
[C08CA04, nicardipine, Nicardipine may increase the hypotensive activities of Perindopril.]
[C04AE02, nicergoline, Nicergoline may decrease the antihypertensive activities of Perindopril.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Perindopril is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Niflumic acid is combined with Perindopril.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Perindopril is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the hypotensive activities of Perindopril.]
[C08CA07, nisoldipine, Nisoldipine may increase the hypotensive activities of Perindopril.]
[C08CA08, nitrendipine, Perindopril may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Perindopril.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Perindopril.]
[N05CF03, zaleplon, Perindopril may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Perindopril.]
[C02DD01, nitroprusside, Nitroprusside may increase the hypotensive activities of Perindopril.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Perindopril.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Perindopril.]
[C02KX01, bosentan, Bosentan may increase the hypotensive activities of Perindopril.]
[N06AA10, nortriptyline, Nortriptyline may decrease the antihypertensive activities of Perindopril.]
[G02CA02, nylidrin, Nylidrin may decrease the antihypertensive activities of Perindopril.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Reviparin.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Perindopril.]
[N02AA02, opium, Perindopril may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Perindopril.]
[B01AD07, reteplase, The risk or severity of angioedema can be increased when Reteplase is combined with Perindopril.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Perindopril.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05BA04, oxazepam, Perindopril may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, Perindopril may increase the hypotensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Perindopril.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Perindopril can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Perindopril.]
[J04AA01, aminosalicylic acid, The risk or severity of renal failure can be increased when Aminosalicylic acid is combined with Perindopril.]
[N05AH05, asenapine, Asenapine may decrease the antihypertensive activities of Perindopril.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Danaparoid.]
[J04AB30, capreomycin, Perindopril may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Perindopril is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Perindopril.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[G04BD11, fesoterodine, Perindopril may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Perindopril may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Perindopril may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Perindopril.]
[L01XX08, pentostatin, Perindopril may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Perindopril.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Perindopril.]
[C08EX02, perhexiline, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Perhexiline.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Perindopril.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Perindopril.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may decrease the antihypertensive activities of Perindopril.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Perindopril.]
[V03AB36, phentolamine, Phentolamine may decrease the antihypertensive activities of Perindopril.]
[M02AA01, phenylbutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Phenylbutazone is combined with Perindopril.]
[S01GA05, phenylephrine, Phenylephrine may decrease the antihypertensive activities of Perindopril.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Perindopril.]
[S01AE05, levofloxacin, Perindopril may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Perindopril may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C08CX01, mibefradil, Perindopril may increase the hypotensive activities of Mibefradil.]
[C07AA03, pindolol, Perindopril may increase the hypotensive activities of Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N06BX03, piracetam, Perindopril may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Piroxicam is combined with Perindopril.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N02CX01, pizotyline, Pizotifen may decrease the antihypertensive activities of Perindopril.]
[C09CA04, irbesartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindopril is combined with Irbesartan.]
[S01XA13, alteplase, The risk or severity of angioedema can be increased when Perindopril is combined with Alteplase.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C03AA05, polythiazide, The therapeutic efficacy of Perindopril can be increased when used in combination with Polythiazide.]
[A10BH03, saxagliptin, The risk or severity of angioedema can be increased when Saxagliptin is combined with Perindopril.]
[B05XA01, potassium chloride, The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Perindopril.]
[V03AB21, potassium iodide, The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Perindopril.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Perindopril is combined with Insulin lispro.]
[C07AB01, practolol, Perindopril may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Perindopril.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C01DX02, prenylamine, The risk or severity of hyperkalemia can be increased when Perindopril is combined with Prenylamine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Perindopril.]
[M04AB01, probenecid, Perindopril may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Perindopril may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Perindopril.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Perindopril.]
[C10AB05, fenofibrate, Perindopril may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, Promazine may decrease the antihypertensive activities of Perindopril.]
[R06AD02, promethazine, Perindopril may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Perindopril.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[N05AC01, periciazine, Periciazine may decrease the antihypertensive activities of Perindopril.]
[N05CM06, propiomazine, Propiomazine may decrease the antihypertensive activities of Perindopril.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Perindopril.]
[C07AA05, propranolol, Propranolol may increase the hypotensive activities of Perindopril.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Perindopril.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Perindopril.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Perindopril.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Perindopril.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Perindopril.]
[N07XX07, dalfampridine, Perindopril may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Perindopril may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[A12BA05, potassium gluconate, The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Perindopril.]
[C01BA01, quinidine, Perindopril may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, Quinine may increase the hypotensive activities of Perindopril.]
[A02BA02, ranitidine, Perindopril may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, The risk or severity of angioedema can be increased when Perindopril is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Perindopril.]
[J05AP01, ribavirin, Perindopril may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Perindopril.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Perindopril.]
[N02BA05, salicylamide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylamide is combined with Perindopril.]
[A07EC01, sulfasalazine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Perindopril.]
[S01BC08, salicylic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Perindopril.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Perindopril.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Perindopril.]
[L01FA03, obinutuzumab, Perindopril may increase the hypotensive activities of Obinutuzumab.]
[J01GB08, sisomicin, Perindopril may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Perindopril may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Perindopril may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Perindopril.]
[C03DA01, spironolactone, The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Perindopril.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide mononitrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tiaprofenic acid is combined with Perindopril.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
